The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ASC2ESCALATE: A US phase 2, single-arm, dose-escalation study of asciminib monotherapy in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) previously treated with 1 prior tyrosine kinase inhibitor (TKI).
 
Ehab L. Atallah
Consulting or Advisory Role - Abbvie/Genentech; Bristol-Myers Squibb; Jazz Pharmaceuticals; Novartis; Pfizer; Syndax; Takeda
Speakers' Bureau - Abbvie; Bristol-Myers Squibb/Celgene; Celgene
Research Funding - Novartis (Inst); Takeda (Inst)
 
Michael J. Mauro
Honoraria - Abbvie; Bristol Myers Squibb Foundation; Novartis; Pfizer; Takeda
Consulting or Advisory Role - Abbvie; Bristol Myers Squibb Foundation; Novartis; Pfizer; Takeda
Research Funding - Abbvie; Bristol Myers Squibb Foundation; Novartis; Pfizer; Takeda
Travel, Accommodations, Expenses - Abbvie; Bristol Myers Squibb Foundation; Novartis; Pfizer; Takeda
 
Koji Sasaki
Honoraria - Amgen; Chugai Pharma; Otsuka
Consulting or Advisory Role - Novartis; Pfizer; Takeda
Research Funding - Novartis
Travel, Accommodations, Expenses - Otsuka
 
Moshe Y. Levy
Stock and Other Ownership Interests - Actinium Pharmaceuticals; Bluebird Bio; CTI; Karyopharm Therapeutics
Honoraria - Abbvie; Amgen; AstraZeneca; BeiGene; Bristol Myers Squibb Foundation; CTI; Gennao Bio; Gilead Sciences; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; MorphoSys; Novartis; Pfizer; Seagen; Takeda
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; BeiGene; Bristol Myers Squibb Foundation; CTI; Gennao Bio; Gilead Sciences; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; MorphoSys; Novartis; Pfizer; Seagen; Takeda
Speakers' Bureau - Abbvie; Amgen; AstraZeneca; BeiGene; Bristol Myers Squibb Foundation; CTI; Gennao Bio; Gilead Sciences; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; MorphoSys; Novartis; Pfizer; Seagen; Takeda
Travel, Accommodations, Expenses - Abbvie; Amgen; AstraZeneca; BeiGene; Bristol Myers Squibb Foundation; CTI; Gennao Bio; Gilead Sciences; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; MorphoSys; Novartis; Pfizer; Seagen; Takeda
 
Paul B. Koller
Consulting or Advisory Role - Ascentage Pharma; Bristol Myers Squibb Foundation; Daiichi Sankyo Pharmaceutical; Novartis; Takeda
Speakers' Bureau - Novartis; Takeda
Other Relationship - Treadwell Therapeutics
 
Islam Sadek
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Daisy Yang
Employment - Novartis
 
Julie Ruckel-Kumar
Employment - Novartis
 
Mahmudul H Khan
Stock and Other Ownership Interests - Novartis
 
Jorge E. Cortes
Consulting or Advisory Role - Bio-Path Holdings, Inc; Bristol-Myers Squibb; Centessa Pharmaceuticals; Gilead Sciences; Menarini; Novartis; Pfizer; Takeda
Research Funding - Abbvie/Genentech (Inst); Actuate Therapeutics (Inst); Astellas Pharma (Inst); Bio-Path Holdings, Inc (Inst); Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Sellas Life Sciences (Inst); Sun Pharma (Inst); Takeda (Inst)